Atlas Trials

Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil

Clinical trial NCT03399604 · COMPLETED

Trial details

NCT number
NCT03399604
Sponsor
Liquidia Technologies, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Pulmonary Hypertension
Start date
2018-01-02
Primary completion
2019-05-06
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.